| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Adenosine and several of its analogues produced a concentration-dependent shortening of calcium-dependent action potential (c.a.p.) duration of mouse dorsal root ganglion (d.r.g.) neurones in dissociated cell culture. The following rank order of potency was obtained: N6-(L-phenylisopropyl)adenosine greater than N6-(D-phenylisopropyl)adenosine greater than N6-cyclohexyladenosine greater than 2-chloroadenosine much greater than 1-methylisoguanosine greater than adenosine. Effects of adenosine agonists on c.a.p. duration were blocked by methylxanthine adenosine antagonists. Adenosine monophosphate (AMP) and cyclic AMP shortened c.a.p.s in d.r.g. neurones, while ATP also depolarized cells. Voltage-clamp analysis revealed that the effect arose from reduction of a voltage-dependent calcium conductance. Adenosine agonists reduced depolarization-evoked inward currents but did not alter membrane conductance following blockade of calcium channels by cadmium. Additionally, adenosine reduced the instantaneous current-voltage slope (chord conductance) during step commands that produced maximal activation of voltage-dependent calcium conductance. If effects of adenosine on neuronal somata and synaptic terminals are similar, adenosine agonists may inhibit neurotransmitter release in the central nervous system by inhibiting a voltage-dependent calcium conductance. Since effects of adenosine agonists did not correspond with their relative potencies as modulators of adenylate cyclase activity or inhibitors of neurotransmitter release in peripheral tissues, a novel adenosine receptor may be involved in regulation of this conductance.
This article has been cited by other articles:
|
|
 |
|
  M. Synowitz, R. Glass, K. Farber, D. Markovic, G. Kronenberg, K. Herrmann, J. Schnermann, C. Nolte, N. van Rooijen, J. Kiwit, et al. A1 Adenosine Receptors in Microglia Control Glioblastoma-Host Interaction. Cancer Res., September 1, 2006; 66(17): 8550 - 8557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Li, D. Conklin, H.-L. Pan, and J. C. Eisenach Allosteric Adenosine Receptor Modulation Reduces Hypersensitivity Following Peripheral Inflammation by a Central Mechanism J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 950 - 955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Chizh and P. Illes P2X Receptors and Nociception Pharmacol. Rev., December 1, 2001; 53(4): 553 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Carruthers, L. A. Sellers, D. W. Jenkins, E. M. Jarvie, W. Feniuk, and P. P. A. Humphrey Adenosine A1 Receptor-Mediated Inhibition of Protein Kinase A-Induced Calcitonin Gene-Related Peptide Release from Rat Trigeminal Neurons Mol. Pharmacol., June 1, 2001; 59(6): 1533 - 1541. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Belfrage, M. Segerdahl, S. Arner, and A. Sollevi The Safety and Efficacy of Intrathecal Adenosine in Patients with Chronic Neuropathic Pain Anesth. Analg., July 1, 1999; 89(1): 136 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.A. Armour Myocardial ischaemia and the cardiac nervous system Cardiovasc Res, January 1, 1999; 41(1): 41 - 54. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Middlekauff, S. A. Rivkees, H. E. Raybould, M. Bitticaca, J. I. Goldhaber, and J. N. Weiss Localization and functional effects of adenosine A1 receptors on cardiac vagal afferents in adult rats Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H441 - H447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Crea and A. Gaspardone New Look to an Old Symptom: Angina Pectoris Circulation, November 18, 1997; 96(10): 3766 - 3773. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
